Skip to main content

Magnetic resonance imaging of pure ovarian dysgerminoma: a series of eight cases

Abstract

Background

Imaging findings have a prominent role in early and correct identification of ovarian dysgerminoma, the most common ovarian malignant germ cell tumor (OMGCT). Despite Computed Tomography (CT) is widely used, Magnetic Resonance Imaging (MRI) has proved to be superior in adnexal masses characterization. Limited data and small series are available concerning MRI aspects of dysgerminoma.

Case presentation

From January 2012 to December 2018, a database of solid ovarian masses was retrospectively reviewed. Eight patients with histologically proven pure ovarian dysgerminoma and complete imaging available were identified and analyzed. Imaging findings were evaluated separately by two radiologists expert in female genito-urinary MRI.

Conclusions

MRI findings of a lobulated, purely solid, encapsulated mass with hyper-intensity of lobules and hypo-intensity of septa on T2w images contribute to differentiate dysgerminomas from other ovarian neoplasms.

Background

Dysgerminoma, the ovarian counterpart of testicular seminoma, is the most common OMGCT, accounting for 1-2% of primary ovarian neoplasms and 32.8-37.5% of all OMGCTs [1]. Compared to epithelial cancers, OMGCTs are less invasive and have a favorable prognosis following surgery, even in the most advanced cases [1,2,3]. In particular, the prognosis of ovarian dysgerminomas is excellent, with a 5-year survival rate of almost 100% [4]. Therefore, an early and correct diagnosis of these neoplasms is of great importance.

The onset symptoms include acute or chronic pain, abdominal distension, menstrual irregularities and infertility. This tumor is commonly associated with elevated levels of lactate dehydrogenase (LDH) and occasionally with elevated beta human chorionic gonadotrophin (beta-HCG). Elevations in alpha-fetoprotein (AFP) and Cancer Antigen 125(CA-125) are less common [5]. Differently from several other ovarian neoplasms, no specific laboratory tumor markers are correlated with this histotype. In vast majority of cases, dysgerminomas are incidentally diagnosed in asymptomatic womens [1,2,3].

The main imaging findings of dysgerminoma include a well-marginated solid lobulated mass with fibrovascular septa. However, this feature is unspecific for dysgerminoma [6]. Despite CT is widely used in detecting female pelvic masses, MRI has prove to be superior in their characterization [7]. However, at the state of art, limited data are available concerning MRI characteristics of dysgerminoma, furthermore described in small sample series [8,9,10].

The aim of the present study is to describe MRI characteristics of dysgerminoma in a consecutive series of patients, with proven histological diagnosis of this rare tumor.

Case presentation

Materials and methods

From January 2012 to December 2018, a database of solid ovarian masses histologically proven was retrospectively reviewed and imaging characteristics of ovarian dysgerminomas confirmed at histology were collected. Eight patients with ovarian dysgerminoma and complete imaging were identified and analyzed.

Demographic, clinical and laboratory data of these patients are reported in Table 1.

Table 1 Demographic,clinical and laboratory data of study population

The median age was 22.6(13-39) years. One patient was asymptomatic; the remaining patients demonstrated the following symptoms: chronic pelvic pain (n = 3; 38%), infertility (n = 2; 25%), irregular menstruation (n = 2; 25%), abdominal distension (n = 2; 25%), acute pelvic pain (n = 3; 37.5%). Four patients (50%) complained of two of those symptoms. In 3 patients (37.5%), a palpable mass was detectable at physical examination.

One patient was pregnant at the time of diagnosis. Seven patients were nulliparous (87.5%), one was multiparous (12.5%). None was previously submitted to abdominal-pelvic surgery. One patient had uretero-pelvic junction syndrome with right hydronephrosis.

Serum tumor markers showed an elevated LDH value in 6 patients (75%), elevated CA-125 in one patient (12.5%), elevated beta-HCG in one case (12.5%), normal values of AFP in all cases.

After the admission, all the patients were submitted to trans-abdominal sopra-pubic US completed with Doppler ultrasonography, with the evidence of a pelvic mass. Two patients with acute pelvic pain underwent urgent abdomino-pelvic CT. Finally all the patients underwent MRI.

CT examinations were performed using a 64-detector-row scanner. After plain scanning, images were acquired at 30s-60s-90s after contrast medium administration.

MR exams were performed on 6 h fasting patients, pre-medicated with Hyoscine-N-butylbromide antispasmodic agent, via 1.5 superconductive magnet (Excelart Vantage, Toshiba Medical System, Japan) with phased array surface coil. The sequences included followed the ESUR recommendations for MRI of indeterminate adnexal masses [11]. The contrast-enhanced T1w Fast Spoiled 3D Fat Sat gradient-echo were dynamically acquired after iv injection of Gadobenate dimeglumine (Gd-DTPA, 0.1 mmol/Kg, injection speed 3 ml/sec) on axial, sagittal and coronal plans. Dynamic sequences were obtained at 30,60,90 and 120 s after the injection of Gd-DTPA.

MR images were retrospectively evaluated separately by two radiologists with 15 years of pertinent clinical experience in female imaging, who were blinded to clinical, histopatological, endoscopic and other imaging findings.

The following characteristics were collected: maximum diameter of the neoplasm (cm), morphology (roundish, ovoidal, lobulated) internal structure (solid, cystic, mixed cystic-solid), the presence of capsule, interlobular septa, papillary projections, parietal irregularities, calcifications (yes/no). The lesion signal intensity was compared to that of muscle tissue and judged as hypo, iso or hyper-intense and homogeneous or heterogeneous. Endolesional areas of hypo-intensity on T1-weighted images(T1w) and hyper-intensity on T2w (pure fluid signal) were classified as cystic. Areas of iso-intensity on T1w and mild hyper-intensity on T2w were classified as solid. Areas of hyper-intensity on T1w, although punctiform, with a corresponding hyper or hypointense signals on T2w, were classified as hemorrhagic.

The analysis included the evaluation of DWI signal with corresponding ADC values and the enhancement patterns of the mass and septa on T1w contrast enhanced images. Furthermore, the invasion of adjacent structures, lymphnodes number and size and the presence of endoperitoneal fluid effusions were evaluated.

Proper surgically resected specimens were submitted to an accurate hystological and cytological examination performed by a gynecologic pathologist.

Results

All the neoplasms were unilateral. The mean diameter of the lesions was 11.9 cm (3.8-23.5 cm).

At US examinations, lesions appeared as solid masses with non-homogeneous eco-structure, with multiple endolesional hyperechoic components and vascularized septa. At CT scan the masses appeared as solid, lobulated, isodense to muscle tissues, with a moderate enhancement of wall and of endolesional fibrovascular septa (Fig. 1).

Fig. 1
figure 1

Ovarian dysgerminoma in a 19-year-old woman. Color-Doppler US images (a) show a hypervascular solid ovarian mass. Axial contrast-enhanced CT (b) shows a large-sized multilobulated right ovarian mass with enhancing septa within the lobules. Axial T1w (c), axial Fat Sat T2w (d), sagittal contrast-enhanced T1w (e) MR images show a well-marginated giant multilobulated mass in the right ovary, isointense to the muscle tissue on T1w, with hyper-intense lobules and hypo-intense septa on T2w. After contrast administration a progressive enhancement of the septa is observed

The morphology of the lesions was lobulated in 5 patients (62.5%), roundish in 2 patients (25%) and ovular in one patient.

The internal structure of the neoplastic masses was considered purely solid in 7 patients (87.5%) and mixed cystic-solid in one patient (12.5%). In 6 patients (75%), both interlobular fibrous septa and an identifiable thin and regular capsule were observed.

No solid papillary mural projections, parietal irregularities or calcifications were detected (Fig. 2).

Fig. 2
figure 2

Ovarian dysgerminoma in a 20-year-old woman. Sagittal Fat Sat T2w (a), sagittal contrast-enhanced T1w (b), axial T1w (c) MR images show a capsulated giant multilobulated mass displacing both bladder and uterus, isointense to the muscle tissue on T1w, with multiple lobules hyper-intense on T2w, separated by thin, regular, hypo-intense septa with avid enhancement after Gd administration. No papillary projection, parietal irregularities or calcifications are noted

MR signal of the lesions was characterized by a predominant iso-intensity on T1w sequences and a moderate hyper-intensity on T2w (n = 8 pts.,100%), suggesting a solid appearance. On T2w sequences, septa were clearly identifiable as linear hypo-intensities in 6 (75%) cases. In 6 lobulated masses (75%) the signal was described as homogeneous; in 2 cases (25%) as heterogeneous.

Heterogeneous lesions showed hemorrhagic foci visible as focal hyper-intensity on T1w and hyper-intensity on T2w in one patient and cystic lacunae (hypo-intensity on T1 and hyper-intensity on T2w) in the other one. Mean ADC values, calculated from three b-values (0, 500,1000 s/mm2) on the solid areas were 0.81 × 10 - 3 mm2 (minimum 0.92, maximum 1.32). High signal intensity within the solid component on DWI and low signal intensity in corresponding ADC maps were observed in 8 patients (100%) (Fig. 3).

Fig. 3
figure 3

Ovarian dysgerminoma in a 34-year-old woman. Axial T1w (a), axial T2w (b), axial DWI (c), axial contrast-enhanced T1w with fat-suppression (d). MR images show an ovoidal, lobulated left ovarian mass, isointense on T1w, with heterogeneous predominantly hyper-intense signal on T2w, a restricted diffusion signal on DWI and an avid enhancement after Gd administration, with interlobular septa

After Gadolinium administration, a progressive enhancement of the fibrovascular septa and of the lobules was detected in 7 patients (87.5%) (Fig. 4). No contrast enhancement was detectable in the remaining patient.

Fig. 4
figure 4

Ovarian dysgerminoma in a 23-year-old woman with recurrence after surgery. Axial T2w (a), axial contrast-enhanced T1w with fat-suppression (b) MR images show a multilobulated heterogeneous large-sized cystic-solid pelvic mass with interspersed septa and avid enhancement after Gd administration. The mass was surgically removed and stage II dysgerminoma was diagnosed. Two years after surgical treatment, during a routine follow-up, we revealed a recurrence in the right emipelvis, characterized by heterogeneous hyperintense signal on axial T2w (c), high signal and low values on DWI and ADC images (d, e), heterogenous moderate enhancement after Gd administration (f)

In 2 cases (25%), a small amount of fluid effusion was observed in recto-uterine Douglas pouch.

In 2 patients (25%) lymph-nodes with short axis > 1 cm were documented in the right groin and in the left internal iliac region, respectively.

MRI findings are reported in Table 2.

Table 2 MRI findings

Discussion and conclusions

Radiological aspects of ovarian dysgerminoma have poorly discussed in current literature. The largest multicenter radiological series have evaluated sonographic characteristics of dysgerminoma in 21 patients [7].

MR features of dysgerminoma were previously described in small series as solid masses divided into lobules by hypointense or isointense on T2w fibrovascular septa, which showed a marked enhancement after Gd-DTPA injection [8,9,10]. Tsuboyama et al. described three cases of non-pure dysgerminomas coexisting with other OMGCTs, being the only study reporting the presence of a high DWI signal in one case of ovarian solid mass [10]. Our series of 8 patients is one of the largest in literature including mutiparametric MRI findings and histological confirmation of pure dysgerminomas.

In the most of our cases dysgerminoma appeared as a purely solid encapsulated mass with hyper-intensity of lobules and linear hypo-intensity of septa on T2w imaging. This sign reflects the hyper-cellularity of the lobules and the fibrous nature of the septa and may help to differentiate dysgerminomas from other OMGCTs [12, 13]. The only case of mixed cystic-solid mass was noticed in an extra-ovarian (stage II) disease with a two-years cancer recurrence after radical surgery. This finding may suggest a more malignant behavior of heterogeneous mixed cystic-solid lesions compared to the purely solid ones. Contrast enhanced images may also help in differentiating dysgerminomas from other OMGCTs. In the lesions of our series, progressive enhancement of fibrovascular septa and a moderate enhancement of the lobules was observed. The other OMGCTs may also show an hypervascular behaviour although with an heterogeneous and messy structure [14, 15].

Our findings may also contribute to differentiate dysgerminomas from solid non-OMGCTs tumors including fibrotecoma, Brenner’s tumor and granular cell tumor. The first two are hypo-intense on T2w and the latter is frequently characterized by hemorrhagic endolesional areas, hyper-intense on T1w images [15]. Moreover, hemorragic foci in dysgerminoma are less common than in solid portion of other OMGCTs such as Yolk sack tumor, nongestational choriocarcinoma and embryonal carcinoma. Massive necrosis, endolesional calcifications and “ovarian vascular pedicle” sign were not detected in our cases, this latter present in up to 92% of lesions of Zhao et al. series and mostly due to thickened and tortuous ipsilateral ovarian vein [13]. The lack of endolesional calcifications and necrotic foci may also help in the differential diagnosis with epithelial carcinomas.

High signal on DWI within the solid mass with corresponding low ADC values was reported in all our cases and reflect the hypercellular environment. Nevertheless, high DWI signal and low ADC values may be observed in false-positive non-malignant lesions with high cellular density [16]. Thus, DWI should always be combined with morphological sequences.

The present study has some limitations, such as the retrospective design, that however represents a limitation typical for this very rare pathology, the small number of patients and the subjective interpretation of images.

In conclusion, our series is one of the largest available in literature including only one pure subtype of OMGCT, which is in its own very rare, analyzed by the same group of radiologists and pathologists and collected in a single center. In our series, multiparametric MR imaging is able to express its full potential in the detection and characterization of ovarian masses. Furthermore, MRI may contribute to differentiate dysgerminoma from others OMGCTs, solid non-OMGCTs and epithelial ovarian tumors. Concurrently, MRI plays an important role in local and extra-ovarian staging of dysgerminoma, in the preoperative planning and in the detection of recurrencies.

Availability of data and materials

The authors confirm that the data supporting the findings of this study are available within the article and its supplementary materials.

Abbreviations

OMGCT:

Ovarian malignant germ cell tumor

non-OMGCTs:

Non-germ cell ovarian malignant tumor

CT:

Computed Tomography

MRI:

Magnetic Resonance Imaging

T1w:

T1 weighted image

T1w:

T2 weighted image

References

  1. Gallion HH, Van Nagel JR, Donaldson ES, Powell DE. Ovarian dysgerminoma: report of seven cases and review of the literature. Am J Obstet Gynecol. 1988;158:591–5. https://doi.org/10.1016/0002-9378(88)90036-1.

    CAS  Article  PubMed  Google Scholar 

  2. Gordon A, Lipton D, Woodruff JD. Dysgerminoma: a review of 158 cases from the Emil Novak ovarian tumor registry. Obstet Gynecol. 1981;58:497–504.

    CAS  PubMed  Google Scholar 

  3. Talerman A. Germ cell tumors of the ovary. In: Kurman RJ, editor. Blaustein pathology of the female genital tract. 5th ed. New York: Springer-Verlag; 2002. p. 967–1033.

    Google Scholar 

  4. Momenimovahed Z, Tiznobaik A, Taheri S, Salehiniya H. Ovarian cancer in the world: epidemiology and risk factors. Int J Women's Health. 2019;11:287–99. https://doi.org/10.2147/IJWH.S197604.

    Article  Google Scholar 

  5. Pectasides D, Pectasides E, Kassanos D. Germ cell tumors of the ovary. Cancer Treat Rev. 2008;34:427–41. https://doi.org/10.1016/j.ctrv.2008.02.002.

    CAS  Article  PubMed  Google Scholar 

  6. Lazebnik N, Balog A, Bennet S, Redline R, Liu J. Ovarian dysgerminoma: a challenging clinical and sonographic diagnosis. J Ultrasound Med. 2009;28:1409–15. https://doi.org/10.7863/jum.2009.28.10.1409.

    Article  PubMed  Google Scholar 

  7. Guerriero S, Testa AC, Timmermann D, Van Holsbeke C, Ajossa S, Fischerova D, et al. Imaging of gynecological disease (6): clinical and ultrasound characteristics of ovarian dysgerminoma. Ultrasound Obstet Gynecol. 2011;37:596–602. https://doi.org/10.1002/uog.8958.

    CAS  Article  PubMed  Google Scholar 

  8. Tanaka YO, Kurosaki Y, Nishida M, Michishita N, Kuramoto K, Itai Y, et al. Ovarian dysgerminoma: MR and CT appearance. J Comput Assist Tomogr. 1994;18(3):443–8.

    CAS  Article  Google Scholar 

  9. Kim SY, Kang SB. Ovarian dysgerminoma: color Doppler Ultrasonographic findings and comparison with CT and MR findings. J Ultrasound Med. 1995;14:843–8. https://doi.org/10.7863/jum.1995.14.11.843.

    CAS  Article  PubMed  Google Scholar 

  10. Tsuboyama T, Hori Y, Hori M, Onishi H, Tatsumi M, Sakane M, et al. Imaging findings of ovarian dysgerminoma with emphasis on multiplicity and vascular architecture: pathogenic implicantions. Abdom Radiol. 2018;43(7):1515–23. https://doi.org/10.1007/s00261-018-1503-6.

    Article  Google Scholar 

  11. Forstner R, Thomassin-Naggara I, Forstner CTM, R, Thomassin-Naggara I, Cunha TM, Kinkel K, Masselli G, Kubik-Huch R, Spencer JA, Rockall A. ESUR recommendations for MR imaging of the sonographically indeterminate adnexal mass: an update. Eur Radiol. 2017;27(6):2248–57. https://doi.org/10.1007/s00330-016-4600-3.

    Article  PubMed  Google Scholar 

  12. Shaaban AM, Rezvani M, Elsayes KM, Baskin H Jr, Mourad A, Foster BR, et al. Ovarian malignant germ cell tumors: cellular classification and clinical and imaging features. Radiographics. 2014;34:777–801. https://doi.org/10.1148/rg.343130067.

    Article  PubMed  Google Scholar 

  13. Zhao S, Sun F, Bao L, Chu C, Li H, Yin Q, et al. Pure dysgerminoma of the ovary: CT and MRI features with pathological correlation in 13 tumors. J Ovarian Res. 2020;13(1):7. https://doi.org/10.1186/s13048-020-00674-z.

    Article  Google Scholar 

  14. Wang Q, Yu D, Wang F. Clinical and computed tomography features of female pelvic malignant germ cell tumors in children and adolescents: a series of 30 cases. J Pediatr Adolesc Gynecol. 2020;33(1):83–8. https://doi.org/10.1016/j.jpag.2019.10.003.

    Article  PubMed  Google Scholar 

  15. Spencer JA, Ghattamanemi S. MR imaging of the Sonographically indeterminate adnexal mass. Radiology. 2010;256(3):677–89. https://doi.org/10.1148/radiol.10090397.

    Article  PubMed  Google Scholar 

  16. Vargas HA, Barrett T, Sala E. MRI of ovarian masses. JMRI. 2013;37:265–81. https://doi.org/10.1002/jmri.23721.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

Author information

Authors and Affiliations

Authors

Contributions

LMC and FC have given substantial contributions to the conception or the design of the manuscript, FM and MD to acquisition, analysis and interpretation of the data. All authors have participated to drafting the manuscript, MR and RG revised it critically. All authors read and approved the final version of the manuscript.

Corresponding author

Correspondence to Laura Maria Cacioppa.

Ethics declarations

Ethics approval and consent to participate

This study has been granted an exemption from requiring ethics approval by the ethics committee of the University of Bologna.

An informed consent to participate in the study was obtained from participants.

Consent for publication

Written informed consent for publication of their clinical details and clinical images was obtained from the patients.

Competing interests

The authors declare that they have no competing interests.

The authors certify that there is no conflict of interest with any financial organization regarding the material discussed in the manuscript.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Cacioppa, L.M., Crusco, F., Marchetti, F. et al. Magnetic resonance imaging of pure ovarian dysgerminoma: a series of eight cases. Cancer Imaging 21, 58 (2021). https://doi.org/10.1186/s40644-021-00427-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40644-021-00427-1

Keywords

  • Ovarian neoplasms
  • Dysgerminomas
  • Magnetic resonance imaging
  • Diffusion MRI
  • Computed tomography